Cambridge Epigenetix IPO

Cambridge Epigenetix (CEGX) is a life sciences tools and analytics company that has created a technology platform delivering step changes in both the type of information that can be generated from DNA and the cost at which it is gathered.

Register for Details

For more details on financing and valuation for Cambridge Epigenetix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Cambridge Epigenetix's ticker symbol?

Cambridge Epigenetix does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Cambridge Epigenetix's stock price?

The stock price for Cambridge Epigenetix will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Cambridge Epigenetix Funding Rounds and IPO Valuation

Cambridge Epigenetix IPO has raised $57.08MM

Learn more about Cambridge Epigenetix

What is Cambridge Epigenetix funding to date?

Cambridge Epigenetix has raised $57.08MM

When was Cambridge Epigenetix founded?

Cambridge Epigenetix was founded in 2012.

Can you invest in Cambridge Epigenetix?

Cambridge Epigenetix is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Cambridge Epigenetix share pre-IPO?

If you own Cambridge Epigenetix pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Cambridge Epigenetix a publicly traded company?

Cambridge Epigenetix is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Cambridge Epigenetix in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$4.26B